Cullen Frost Bankers Inc. Grows Stock Holdings in U.S. Physical Therapy, Inc. $USPH

Cullen Frost Bankers Inc. raised its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 171.8% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 443 shares of the company’s stock after buying an additional 280 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in U.S. Physical Therapy were worth $35,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of USPH. Copeland Capital Management LLC increased its stake in U.S. Physical Therapy by 8.9% during the 2nd quarter. Copeland Capital Management LLC now owns 888,735 shares of the company’s stock valued at $69,499,000 after purchasing an additional 72,463 shares in the last quarter. Bahl & Gaynor Inc. increased its stake in U.S. Physical Therapy by 32.6% during the 1st quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company’s stock valued at $24,964,000 after purchasing an additional 84,878 shares in the last quarter. GW&K Investment Management LLC increased its stake in U.S. Physical Therapy by 8.9% during the 1st quarter. GW&K Investment Management LLC now owns 344,390 shares of the company’s stock valued at $24,920,000 after purchasing an additional 28,203 shares in the last quarter. Envestnet Asset Management Inc. increased its stake in U.S. Physical Therapy by 5.6% during the 1st quarter. Envestnet Asset Management Inc. now owns 316,489 shares of the company’s stock valued at $22,901,000 after purchasing an additional 16,698 shares in the last quarter. Finally, Northern Trust Corp increased its stake in U.S. Physical Therapy by 4.7% during the 1st quarter. Northern Trust Corp now owns 274,117 shares of the company’s stock valued at $19,835,000 after purchasing an additional 12,292 shares in the last quarter.

Insider Transactions at U.S. Physical Therapy

In related news, CFO Carey P. Hendrickson sold 698 shares of U.S. Physical Therapy stock in a transaction on Monday, August 25th. The shares were sold at an average price of $86.11, for a total value of $60,104.78. Following the sale, the chief financial officer owned 27,808 shares of the company’s stock, valued at approximately $2,394,546.88. This trade represents a 2.45% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Christopher J. Reading sold 2,000 shares of U.S. Physical Therapy stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $83.53, for a total transaction of $167,060.00. Following the completion of the sale, the chief executive officer directly owned 114,088 shares in the company, valued at $9,529,770.64. This represents a 1.72% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 6,853 shares of company stock worth $581,406 in the last ninety days. Company insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $93.14 on Monday. The stock has a market capitalization of $1.42 billion, a price-to-earnings ratio of 40.67, a PEG ratio of 4.67 and a beta of 1.48. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $101.19. The firm’s 50 day simple moving average is $85.26 and its 200-day simple moving average is $78.89. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The business had revenue of $140.66 million for the quarter. Analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 22nd were paid a $0.45 dividend. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $1.80 dividend on an annualized basis and a yield of 1.9%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 78.60%.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. JPMorgan Chase & Co. assumed coverage on shares of U.S. Physical Therapy in a research report on Thursday, September 18th. They set an “overweight” rating and a $110.00 price target for the company. Zacks Research raised shares of U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Friday. Wall Street Zen lowered shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research report on Sunday, September 21st. Finally, Barrington Research reissued an “outperform” rating and set a $103.00 price target on shares of U.S. Physical Therapy in a research report on Friday. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, U.S. Physical Therapy presently has a consensus rating of “Moderate Buy” and an average target price of $110.25.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.